Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.27 USD | -5.78% | -10.40% | +36.49% |
May. 08 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
May. 08 | Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Keros Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Keros Therapeutics, Inc.
Wedbush | |
BofA Securities | |
Piper Sandler | |
Cowen | |
BTIG | |
Truist Securities |
EPS Revisions
- Stock Market
- Equities
- KROS Stock
- Consensus Keros Therapeutics, Inc.